BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 2:59:00 PM | Browse: 937 | Download: 831
Publication Name World Journal of Immunology
Manuscript ID 4874
Country Japan
Received
2013-07-30 09:05
Peer-Review Started
2013-07-30 21:50
To Make the First Decision
2013-08-21 18:53
Return for Revision
2013-08-28 10:56
Revised
2013-09-02 07:10
Second Decision
2013-10-16 11:18
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-10-16 12:15
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-11-18 11:39
Publish the Manuscript Online
2013-11-29 02:07
ISSN 2219-2824 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Role of IL28B genotype in older hepatitis C virus-infected patients
Manuscript Source Invited Manuscript
All Author List Tatsuo Kanda, Shingo Nakamoto, Shuang Wu and Osamu Yokosuka
Funding Agency and Grant Number
Corresponding Author Tatsuo Kanda, MD, PhD, Associate Professor, Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. kandat-cib@umin.ac.jp
Key Words Hepatitis C virus; Interferon lambda 3; Interleukin-28B; Older patients; Telaprevir
Core Tip The exact mechanisms of the effects of interleukin-28B (IL28B) genotype on the treatment response in chronic hepatitis C patients are unclear. However, IL28B genotype is useful for the continued successful treatment of older patients infected with hepatitis C virus (HCV) and avoiding adverse events. Until the eventual availability of interferon-free regimens, it is important to determine IL28B genotype before treating HCV-infected individuals, especially in the screening of older patients.
Publish Date 2013-11-29 02:07
Citation Kanda T, Nakamoto S, Wu S, Yokosuka O. Role of IL28B genotype in older hepatitis C virus-infected patients. World J Immunol 2013; 3(3): 54-61
URL http://www.wjgnet.com/2219-2824/full/v3/i3/54.htm
DOI http://dx.doi.org/10.5411/wji.v3.i3.54
Full Article (PDF) WJI-3-54.pdf
Manuscript File 4874-Review.doc
Answering Reviewers 4874-Answering reviewers.pdf
Copyright License Agreement 4874-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 4874-Language certificate.doc
Peer-review Report 4874-Peer reviewer(s).pdf
Scientific Editor Work List 4874-Scientific editor work list.doc